Radiation-induced xerostomia in patients with head and neck cancer - A literature review

被引:297
作者
Dirix, Piet [1 ]
Nuyts, Sandra [1 ]
Van den Bogaert, Walter [1 ]
机构
[1] Univ Hosp Gasthuisberg, Dept Radiat Oncol, Leuven Canc Inst, B-3000 Louvain, Belgium
关键词
radiotherapy; head and neck; xerostomia; intensity-modulated radiotherapy;
D O I
10.1002/cncr.22302
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
A dry mouth or xerostomia is one of the most common complications during and after radiotherapy for head and neck cancer, because irreparable damage is caused to the salivary glands, which are included in the radiation fields. Xemstomia not only significantly impairs the quality of life of potentially cured cancer patients, it may also lead to severe and long-term oral disorders. Because management of xerostomia is rarely effective, prevention is paramount. Several strategies have been developed to avoid radiation-induced salivary dysfunction without compromising definitive oncologic treatment. These include salivary gland-sparing radiation techniques, such as 3-dimensional conformal or intensity-modulated radiotherapy, concomitant cytoprotectants, and surgical salivary gland transfer. However, these preventive approaches are not applicable to all patients, and comprehensive scientific research that incorporates new biological insights is warranted to optimize the therapeutic index of radiotherapy for head and neck cancer.
引用
收藏
页码:2525 / 2534
页数:10
相关论文
共 118 条
[1]
MORPHOLOGIC AND HISTOCHEMICAL-STUDIES ON THE DIFFERING RADIOSENSITIVITY OF DUCTULAR AND ACINAR-CELLS OF THE RAT SUBMANDIBULAR-GLAND [J].
ABOK, K ;
BRUNK, U ;
JUNG, B ;
ERICSSON, J .
VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1984, 45 (04) :443-460
[2]
Chemical radioprotection: A critical review of amifostine as a cytoprotector in radiotherapy [J].
Andreassen, CN ;
Gran, C ;
Lindegaard, JC .
SEMINARS IN RADIATION ONCOLOGY, 2003, 13 (01) :62-72
[3]
Ang KK, 2002, RADIOTHERAPY HEAD NE
[4]
A phase II trial of subcutaneous Amifostine and radiation therapy in patients with head and neck cancer [J].
Anné, PR ;
Curran, WJ .
SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :18-19
[5]
[Anonymous], 1995, Radiother Oncol, V35, P17
[6]
[Anonymous], ARCH ELECT MED
[7]
3D MR sialography protocol for postradiotherapy follow-up of the salivary duct system [J].
Astreinidou, Eleftheria ;
Raaymakers, Cornelis P. J. ;
Roesink, Judith M. ;
Terhaard, Chris H. J. ;
Lagendijk, Jan J. W. ;
Bartels, Lambertus W. .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2006, 24 (03) :556-562
[8]
A RETURN TO NORMAL EATING AFTER CURATIVE TREATMENT FOR ORAL-CANCER - WHAT ARE THE LONG-TERM PROSPECTS [J].
BEEKEN, L ;
CALMAN, F .
ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B, 1994, 30B (06) :387-392
[9]
BJORNSTROM M, 1990, SWED DENT J, V14, P153
[10]
Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy [J].
Blanco, AI ;
Chao, KSC ;
El Naqa, I ;
Franklin, GE ;
Zakarian, K ;
Vicic, M ;
Deasy, JO .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (04) :1055-1069